33rd week of 2012 patent applcation highlights part 36 |
Patent application number | Title | Published |
20120207805 | Wipe for Use with a Germicidal Solution - An antimicrobial wipe that contains a polymer coating having a synergistic combination of ingredients for providing controlled release of an antimicrobial agent and also good antimicrobial efficacy is provided. One such ingredient is a high molecular weight polyamideamine release agent. Due to the polycationic nature of the release agent, it is able to adhere to the wipe, which is generally formed from fibers having a negative surface charge (e.g., cellulosic fibers). In this manner, the release agent can occupy binding sites on the wipe to inhibit the antimicrobial agent from adhering thereto, thus allowing it to be expressed in the germicidal solution to kill microbes on the desired surface. The adherence of the release agent to the wipe is even further enhanced by crosslinking the polyamideamine to increase its molecular weight, thereby enabling it to form a structural network that physically adheres to the wipe and that blocks the antimicrobial agent from binding thereto. Furthermore, the polyamideamine is amidated so that it contains secondary and/or tertiary amides. A cell permeabilizer is also employed in the polymer coating to enhance the efficacy of the antimicrobial agent during use. More particularly, polycationic materials are particularly useful in permeabilizing the outer cell membrane without adversely impacting the ability of the polyamideamine to release the antimicrobial agent within the wipe. | 2012-08-16 |
20120207806 | Multi-purpose dental appliance cleaner - A safe and effective antimicrobial composition for conveniently cleaning dental appliances like athletic mouth guards, night guards, orthodontic retainers and Invisalign-style braces, and teeth whitening trays of harmful germs, bacteria, molds, odors, and stains. Such composition comprises a plant-based anti-microbial extract like grapefruit seed extract in combination with a cleaning agent without the need for additional ascorbic acid or metal cation-based antibacterial agents. The cleaning composition can be delivered to the dental appliance as a rinse, wet wipe towelette, or spray for removing a wide variety of gram-negative and gram-positive bacteria and other microorganisms from the dental appliance. | 2012-08-16 |
20120207807 | INSECTICIDE FORMULATIONS - Insecticide formulations having improved chemical and physical stability and related methods are disclosed. The insecticide formulations may include a plurality of microcapsules, each including at least one organophosphate insecticide (e.g., chlorpyrifos-methyl) at least partially surrounded by a polymer shell. The insecticide formulations may be used to control insect populations by singular or periodic applications. The microcapsule polymer shell of the insecticide formulations may be formed by combining a cross-linking amine and a hydrophobic monomer (e.g., an isocyanate) at a molar ratio of amine to isocyanate groups of less than about 1:1. | 2012-08-16 |
20120207808 | DEVICES AND METHODS FOR TREATING DEFECTS IN THE TISSUE OF A LIVING BEING - An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery. Additionally, the implant may be “matched” to provide the implant with similar physical and/or chemical properties as the host tissue. | 2012-08-16 |
20120207809 | Method and system for effecting changes in pigmented tissue - Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are compositions for lightening or darkening the pigmented tissues or treating a pigmented tissue disease. | 2012-08-16 |
20120207810 | Kinase Inhibitors - The present invention relates to drug delivery systems comprising ocular implant, which include organic molecules, capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation, in combination with a polymer, which polymer serves to control, modify, modulate and/or slow the release of the therapeutic component into the environment of the eye in which said composite is placed. | 2012-08-16 |
20120207811 | Textile material for management of skin health complications associated with skin folds, and its method of use - A device configured to manage skin health within a skin fold includes a textile material having an antimicrobial silver complex and a liquid translocation feature. The liquid translocation feature is characterized by a transportation of at least 1.0 gram of liquid moisture over at least a 12 cm length of the textile material such that the textile material is configured to concurrently treat moisture accumulation and intertrigo within the skin fold. | 2012-08-16 |
20120207812 | SKINCARE COMPOSITIONS COMPRISING SALICYCLIC ACID - There is disclosed a skincare composition suitable for topical application to the skin. The composition comprises salicylic acid or a salt thereof and hydrolysed milk protein. The composition is useful in the treatment of acne. | 2012-08-16 |
20120207813 | RAPIDLY ACTING DRY SEALANT AND METHODS FOR USE AND MANUFACTURE - Compositions, methods, and kits are provided for sealing applications. Compositions are prepared by combining a first cross-linkable component with a second cross-linkable component to form a porous matrix having interstices, and combining the porous matrix with a hydrogel-forming component to fill at least some of the interstices. The compositions exhibit minimal swelling properties. | 2012-08-16 |
20120207814 | AQUEOUS PATCHES CONTAINING DICLOFENAC SODIUM - An aqueous patch containing diclofenac sodium, wherein the patch contains a homogeneous mixed solution of diclofenac sodium, wherein the solution is obtained by mixing crotamiton, diclofenac sodium and water in the mixture ratio of crotamiton/diclofenac sodium of 8.0 or less and the mixture ratio of (water+crotamiton)/diclofenac sodium of 3.0-20.0. | 2012-08-16 |
20120207815 | METHOD OF TREATING EOSINOPHILIC ESOPHAGITIS - The present invention relates to the treatment of EE. More specifically, the invention relates to a new method of treating EE through the epicutaneous route. In particular, the method of the invention comprises applying to the skin of the subject a skin patch device, comprising a composition, under conditions allowing a contact between said composition and the skin. The present invention also relates to the skin patch device and to a use of the skin patch device in the manufacture of a composition for treating eosinophilic esophagitis in a subject. | 2012-08-16 |
20120207816 | Transdermally Absorbable Donepezil-Containing Preparation - Provided is a donepezil-containing transdermal absorption formulation that can sustainably administer donepezil for a long period of time, and can provide both a rapid increase in the blood level of donepezil and donepezil sustained release properties. The donepezil-containing transdermal absorption formulation is a transdermal absorption formulation produced by dissolving donepezil, which is the active ingredient, in an adhesive patch base that contains a hydrophobic polymer and an absorption promoter. The absorption promoter is one kind or two or more kinds selected from lauryl alcohol, triethyl citrate, isopropyl myristate, cetyl lactate, oleyl alcohol, sorbitan monooleate, polyethylene glycol monostearate, lauromacrogol, N-methyl-2-pyrrolidone, and triacetin. | 2012-08-16 |
20120207817 | SMALL INTERFERING RNAS AND METHODS FOR PREVENTION, INHIBITION AND/OR TREATMENT OF MALIGNANT PROGRESSION OF BREAST CANCER - The invention found that overexpression and activation of α9-nAChR are associated with tumorigenesis of breast cancer and create a number of small interfering RNAs to inhibit the expression of α9-nAChR so as to inhibit breast cancer. Therefore, the invention provides small interfering RNAs (siRNAs) for inhibiting expression of α9-nAChR so as to inhibit breast cancer, methods to prevent/inhibit/treat malignant progression of nicotine-derived-compound-induced breast cancer and method of determining malignant level of such breast cancer. | 2012-08-16 |
20120207818 | COMPOSITION FOR SUPPRESSING EXPRESSION OF TARGET GENE - The present invention provides a composition that comprises a liposome encapsulating a double-stranded nucleic acid molecule,
| 2012-08-16 |
20120207819 | COMPOSITIONS AND METHODS FOR WOUND HEALING - The present invention is related to the field of wound healing or tissue regeneration due to disease (i.e., for example, cardiovascular diseases, osetoarthritic diseases, or diabetes). In particular, the present invention provides compositions and methods comprising molecules with linked α-gal epitopes for induction of recruitment of macrophages localized within or surrounding damaged tissue. The recruited macrophages recruit stem cells and promote the repair and regeneration of the treated injured tissue. In some embodiments, the present invention provides treatments for tissue repair in normal subjects and in subjects having impaired healing capabilities, such as diabetic and aged subjects. In some embodiments, the present invention provides treatments for injured tissues such as brain, peripheral nerve, heart muscle, skeletal muscle, cartilage, bone, gastrointestinal tract and dysfunctional endocrine tissues. | 2012-08-16 |
20120207820 | COMPOSITION FOR TREATMENT OF MULTIPLE SCLEROSIS - Novel oligopeptides, combinations thereof and fusion proteins composed of the above-mentioned oligopeptides are disclosed. Oligopeptides are homologous in amino acid sequence to the selected parts of the amino acid sequence of human myelin basic protein (MBP) and are capable to ameliorate the progression of multiple sclerosis by means of binding to and inactivation of epitope-specific anti MBP catalytic auto antibodies (ESAMBPCAA) involved into binding and catalytic degradation of MBP in course of progression of Multiple Sclerosis. | 2012-08-16 |
20120207821 | Liposomal formulation and use thereof - Cationic liposome encapsulated antimonial drugs formulations are provided. The drug-loaded liposome have enhanced efficacy as antileismanial agents and provide improved therapeutic index as compared to the minimal dose of free drug. | 2012-08-16 |
20120207822 | COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE - Provided herein are compositions for the treatment and/or prevention of cardiovascular disease (CVD), and methods of application and use thereof. In particular, the present invention provides treatment and/or prevention of cardiovascular disease with 3,3-dimethyl-1-butanol (DMB) and related compounds, and pharmaceutical formulations thereof. In other embodiments, the present invention provides methods of administering a gut flora targeting antibiotic to a subject prior to a procedure that is associated with a risk of causing thrombosis, heart-attack, and/or platelet hyper-responsiveness. | 2012-08-16 |
20120207823 | PHARMACEUTICAL PELLETS COMPRISING MODIFIED STARCH AND THERAPEUTIC APPLICATIONS THEREFOR - Vaginal use compositions comprising pellets prepared from a debranched starch. Pellets may be conveniently prepared via extrusion/spheronization. | 2012-08-16 |
20120207824 | ORALLY EFFECTIVE METHYLPHENIDATE EXTENDED RELEASE POWDER AND AQUEOUS SUSPENSION PRODUCT - An oral methylphenidate powder which is reconstitutable into a final oral aqueous sustained release formulation containing at least about 50%, or at least about 80% by weight water based on the total weight of the suspension, is provided. The powder is a blend containing a combination of an uncoated methylphenidate-ion exchange resin complex, a barrier coated methylphenidate-ion exchange resin complex-matrix, and a water soluble buffering agent such that upon formed into an aqueous liquid formulation, the formulation has a pH in the range of about 3.5 to about 5, or about 4 to about 4.5. Following administration of a single dose of the oral aqueous methylphenidate suspension, a therapeutically effective amount of methylphenidate is reached in less than one hour and the composition provides a twelve-hour extended release profile. | 2012-08-16 |
20120207825 | PHARMACEUTICAL COMPOSITIONS FOR REDUCING ALCOHOL-INDUCED DOSE DUMPING - A pharmaceutical composition is disclosed. The composition comprises a core comprising an active substance or a salt thereof; a separating layer comprising at least one sugar; and a functional layer comprising at least one pharmaceutically acceptable polymer, wherein the composition is resistant to dose dumping in presence of alcohol. | 2012-08-16 |
20120207826 | NOVEL PARASITE THERAPY - There is disclosed herein a composition for treating extracellular parasitic infections, the composition comprising one or more of the following combinations: at least one quinolone or fluoroquinolone together with at least one tetracycline, iodoquinol, an azole or imidazole; or at least two agents selected from the group consisting of iodoquinol, thiazolidones, tetracycline, nitroimidazoles, cotrimoxazole and diloxanide furoate. There is also disclosed herein a method for treating extracellular parasitic infections in a vertebrate in need of said treatment, wherein said treatment comprises administering to said vertebrate a therapeutically effective amount of (i) a composition comprising a quinolone or fluoroquinolone together with a pharmaceutically acceptable carrier or (ii) a composition of the invention or (iii) a combination of at least one quinolone or fluoroquinolone optionally together with at least one tetracycline, iodoquinol, an azole or imidazole; or (iv) a combination of at least two agents selected from the group consisting of iodoquinol, thiazolidones, tetracycline, nitroimidazoles, cotrimoxazole and diloxanide furoate. | 2012-08-16 |
20120207827 | DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS - Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments. | 2012-08-16 |
20120207828 | LARGE DOSE RIBAVIRIN FORMULATIONS - The present invention is related to pharmaceutical dosage forms of ribavirin which are designed to increase patient compliance to a ribavirin therapy. Examples of such dosage forms include 400 mg to 600 mg tablets. These dosage forms are bioequivalent to multiple doses of tablets containing small amounts of ribavirin. | 2012-08-16 |
20120207829 | CALCIUM CARBONATE GRANULATION - Highly compactable granulations and methods for preparing highly compactable granulations are disclosed. More particularly, highly compactable calcium carbonate granulations are disclosed. The granulations comprise powdered materials such as calcium carbonate that have small median particle sizes. The disclosed granulations are useful in pharmaceutical and nutraceutical tableting and provide smaller tablet sizes upon compression than previously available. | 2012-08-16 |
20120207830 | CALCIUM CARBONATE GRANULATION - Highly compactable granulations and methods for preparing highly compactable granulations are disclosed. More particularly, highly compactable calcium carbonate granulations are disclosed. The granulations comprise powdered materials such as calcium carbonate that have small median particle sizes. The disclosed granulations are useful in pharmaceutical and nutraceutical tableting and provide smaller tablet sizes upon compression than previously available. | 2012-08-16 |
20120207831 | COATED SOLID DOSAGE FORMS - The invention is associated with ingestible film coated solid dosage forms comprising natural honey in the coating applied to such forms. The natural honey of the film coated solid dosage form is of sufficient level to be perceived by the user while avoiding sticking to each other or the packaging with which they are in contact and, or storage. | 2012-08-16 |
20120207832 | FORMS OF RIFAXIMIN AND USES THEREOF - Embodiments relate to Rifaximin polymorphic, salt, and hydrate forms, methods of producing polymorphic forms and to their use in medicinal preparations and to therapeutic methods using them. | 2012-08-16 |
20120207833 | FORMS OF RIFAXIMIN AND USES THEREOF - Embodiments relate to Rifaximin polymorphic, salt, and hydrate forms, methods of producing polymorphic forms and to their use in medicinal preparations and to therapeutic methods using them. | 2012-08-16 |
20120207834 | ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS - The present invention relates to oral pharmaceutical compositions with controlled and/or programmed release containing at least one active ingredient having antimicrobial and/or anti-infectious activity for the treatment of infections of the large intestine, in particular the colon. | 2012-08-16 |
20120207835 | BROAD-SPECTRUM BIOCIDE COMPOSITIONS AND A METHOD FOR THEIR PREPARATION - The present invention provides biocide compositions, containing DBNPA encapsulated or absorbed in ceramic powders or xerogels, for preventing the formation of biofilms and for incorporating into paints, coatings, plasters, and plastics. | 2012-08-16 |
20120207836 | DRUG DELIVERY SYSTEMS (WAFER) FOR PEDIATRIC USE - The present invention describes drug delivery compositions in the form of thin water-soluble films (wafers), which contain particles that comprise at least one active ingredient—which is not an estrogen and/or a progestin and/or an alkaline earth metal salt of 5-methyl-(6S)-tetrahydrofolate—and at least one protective agent. The protective agent provides effective taste-masking of the active ingredient due to limited release of the active ingredient in the mouth. The active ingredient is hence not absorbed via the buccal route, but rather via the enteral (per-oral) route. The particles contained in the wafer provided by the present invention have a particle size of below 40 μm thereby resulting in an acceptable sensation in the mouth while dissolving. Such wafers are especially suitable for pediatric use. | 2012-08-16 |
20120207837 | BIOERODIBLE MATRIX FOR TISSUE INVOLVEMENT - Disclosed herein are polyurethane polymer matrices with a porosity of from about 20 microns to about 90 microns that are useful in promoting closure and protection of incision sites; supporting the lower pole position of breast implants; and providing a partial or complete covering of breast implants to provide a beneficial interface with host tissue and to reduce the potential for malpositioning or capsular contracture. The disclosed matrices can be seeded with mammalian cells. | 2012-08-16 |
20120207838 | Treatment of Psoriasis Using Oral Dosage Forms of Nitrone Spin Traps - Psoriasis is treated by oral administration of a pharmaceutical composition containing a nitrone spin trap such as α-phenyl t-butyl nitrone (PBN) and derivatives thereof. Preferred compositions and method of treatments further comprise at least one adjunct ingredient including fatty acid esters of ascorbic acid such as ascorbyl palmitate and ascorbyl stearate. The pharmaceutical composition can be prepared as an immediate release formulation or controlled released formulations. | 2012-08-16 |
20120207839 | Mineralized Collagen/Bioceramic Composite and Manufacturing Method Thereof - The present invention discloses a mineralized collagen/bioceramic composite useful as a hard tissue replacement material or substitute material, comprising about 10% to 95% by weight of mineralized collagen and about 5% to 90% by weight of bioceramics, and a method of manufacturing the same. Wherein, the mineralized collagen is used as a binder for the bioceramics, such as calcium phosphate ceramics, calcium sulfate ceramics, calcium carbonate ceramics, and other biocompatible ceramics. The bioceramic used in the mineralized collagen/bioceramic composite can be either in powder form or in granular form. | 2012-08-16 |
20120207840 | Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Non-Melanoma Skin Cancer - This invention relates to a transdermal delivery system for treating skin related diseases employing protein nanoparticles to deliver drugs to the keratinocytes and basal membrane cells for the treatment of non-melanoma skin cancer. The current invention presents an effective method for delivering small molecule nucleic acids to the epidermal cells. | 2012-08-16 |
20120207841 | FORMULATIONS OF 6-MERCAPTOPURINE - The present invention provides improved formulations of 6-mercaptopurine that exhibit better bioavailability and faster dissolution than previous formulations. | 2012-08-16 |
20120207842 | MULTIPARTICULATE L-MENTHOL FORMULATIONS AND RELATED METHODS - Enteric coated multiparticulate formulations that use L-menthol as an active ingredient are disclosed. In one embodiment, the multiparticulate formulation comprises a plurality of particulates having a reduced release under gastric conditions and an elevated release at neutral pH. The particulates comprise a core comprising L-menthol as an active ingredient. The L-menthol is supplied to the core as an at least 80% pure L-menthol material. An enteric coating is over the core. The enteric coating is effective to release at least about 80% of the L-menthol within about two hours of being placed in a substantially neutral pH environment. Other aspects of the invention include methods of making and methods of using the multiparticulate formulations. | 2012-08-16 |
20120207843 | FLOATING MICROGRANULES - A floating granule having a solid core, on which an active ingredient is supported, and a compound capable of generating a gas discharge which is constituted by an alkaline agent, characterised in that it does not comprise an acid agent that is capable of generating a gas discharge. | 2012-08-16 |
20120207844 | FORMULATIONS BASED ON 3-IODO-2-PROPYNYL BUTYL CARBAMATE - Formulations in water suspension of microcapsules based on 3-iodo-2-propynyl butyl carbamate (IPBC) comprising (parts by weight): (a) 10-60 parts of polymeric microcapsules comprising inside them IPBC and a synergizing agent formed of one or more alkylbenzenes having a number of carbon atoms from 9 to 20; (2) 1-5 parts of one or more dispersants; (3) 1-20 parts of one or more excipients selected from thickeners, antifoam, antifreeze, in can preservative agents; (4) water to 100. | 2012-08-16 |
20120207845 | PHARMACEUTICAL COMPOSITION OF NANOPARTICLES - The invention relates to a method for treating disorders or diseases of a tight junction comprising delivering a pharmaceutical composition of nanoparticles to the tight junction, wherein the nanoparticles consist of positively charged chitosan, a negatively charged substrate, optionally a zero-charge compound, and at least one bioactive agent for treating said disorders or diseases of the tight junction of an animal subject. | 2012-08-16 |
20120207846 | Selenium Nanoparticles with Improvded Biological Effects - Novel methods for biological effective, stable amorphous and monoclinic selenium nanoparticles are disclosed. They are prepared by reacting selenium source with a reducing agent or an oxidative agent in an aqueous media at a temperature between 0-100° C. in the presence of selenium binding polymer molecules such as poly/oligopeptide acids or peptone or nucleic acids or poly/oligosaccharide or their mixtures. | 2012-08-16 |
20120207847 | Cartilage Repair - This invention relates to compositions, methods of preparation thereof, and use thereof for cartilage repair. | 2012-08-16 |
20120207848 | Amniotic Membrane Preparations and Purified Compositions and Therapy for Scar Reversal and Inhibition - Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases. | 2012-08-16 |
20120207849 | Amniotic Membrane Preparations and Purified Compositions and Anti-Angiogenesis Treatment - Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases. | 2012-08-16 |
20120207850 | Methods for Increasing the Kinetic Activity of Alcohol, Water and Other Liquids, so as to Render the Liquids More Useful in Enhancing the Alternative Cellular Energy Pathway in the Prevention and Therapy of Diseases - The kinetic energy of liquids can be increased by several methods described in the present application. The methods include exposure to a magnetic field provided by a rotating or vibrating magnet; exposure to an electromagnetic field provided by an electrical power cord; and placement of the liquid within the vicinity of electrostatic energy and/or sound energy. A previously described method is the bubbling of electrolysis-generated water gas (Brown's Gas) into the liquid. The increased kinetic energy can be demonstrated using a previously described neutral red dye kinetic assay (NR-Kinetic assay). Energized liquids include alcohol, alcoholic beverages and water. The use of the energized solutions to enhance the alternative cellular energy (ACE) pathway in the therapy of individuals is described. | 2012-08-16 |
20120207851 | Biocide compositions and related methods - A composition for producing a biocide solution upon contact with water, the composition comprises at least a hydrogen peroxide donor and polyoxychlorine donor. The biocide solution forms reactive oxygen species when contacted by microorganisms, proteinaceous substances, and reducible organic based contaminants. | 2012-08-16 |
20120207852 | Biocide compositions and related methods - Compositions for producing a biocide solution upon contact with water, the composition comprises at least an acid anhydride and polyoxychlorine donor. The biocide solution forms reactive oxygen species that releases oxygen gas when contacted by microorganisms, proteinaceous substances, and oxidizable organic based contaminants. The biocide solution is free of chlorine dioxide. | 2012-08-16 |
20120207853 | Methods of treating or preventing influenza associated illness with oxidative reductive potential water solutions - The present invention provides methods of treating, reducing, and/or preventing the incidence of an influenza related viral infection in a patient comprising administering a therapeutically effective amount of an oxidative reductive potential (ORP) water solution. The present invention also provides methods of reducing or preventing the incidence of an influenza related viral infection in a patient associated with a medical device comprising contacting the medical device with an effective amount of an ORP water solution. | 2012-08-16 |
20120207854 | METAL POLYSULFIDE-COMPLEX WITH BIOLOGICAL AND CHEMICAL ACTIVITY - Aqueous solution, cream, hydrogel or spray composition containing compound Sn-On-Xn; where S(n=5-8), O (n=3-7) and X═Fe, Cr or Ni, and most effectively, S7-O4-Fe4 as active ingredient for cutaneous, intradermal and subcutaneous treatment of dermo-epithelial lesions, comprising but not limited to, certain types of skin cancer (basal cell, keratocanthoma and spinocellular carcinomas), conjunctivitis, folliculitis, acne, gingivitis, stomatitis, fungal, dermatomycosis, parasitosis, condylomatosis, balanitis, vaginitis, vaginosis, bacteriosis and endometriosis; by reducing the number of infecting microorganism, not limited to | 2012-08-16 |
20120207855 | CEPHALOTAXINE ALKALOID COMPOSITIONS AND USES THEREOF - A method of treatment of a host with a cellular proliferative disease, comprising contacting the host with a cephalotaxine and an antiproliferative agent, each in an amount sufficient to modulate said cellular proliferative disease, is described. In some embodiments, the cephalotaxine comprises homoharringtonine (cephalotaxine, 4-methyl-2-hydroxy-2-(4-hydroxy-4-methyl pentyl)butanediocate ester). Antiproliferative agents of the invention comprise alkylating agents, intercalating agents, metal coordination complexes, pyrimidine nucleosides, purine nucleosides, inhibitors of nucleic acid associated enzymes and proteins, and agents affecting structural proteins and cytoplasmic enzymes. | 2012-08-16 |
20120207856 | MSH3 Expression Status Determines the Responsiveness of Cancer Cells to the Chemotherapeutic Treatment with PARP Inhibitors and Platinum Drugs - Methods for treating a patient at risk for or diagnosed with colorectal cancer are disclosed herein. The method of the present invention determines the overall expression of MSH3 in cells suspected of being colorectal cancer cells from the patient and predicting the efficacy of therapy with a genotoxic anti-neoplastic agent for treating the patient, wherein a decrease in the overall expression of MSH3 in the patient cells when compared to the expression of MSH3 in normal colorectal cells indicates a predisposition to responsiveness to genotoxic anti-neoplastic agent therapy, wherein the therapy comprises administering an effective amount of the genotoxic anti-neoplastic agent therapy to patients. | 2012-08-16 |
20120207857 | Compositions and Methods for Potentiation of Cancer Agents - The present invention includes compositions and method to improve the therapeutic index of anti-cancer agents using a novel anti-cancer agent and a modulator or potentiator thereof | 2012-08-16 |
20120207858 | BIOCIDE AND BLEACH COMPOSITIONS AND RELATED METHODS - Provided are biocide compositions and bleach compositions comprising organic acyl polyoxychlorine and related methods. The reduction of the acyl polyoxychlorine group releases a reactive intermediate that undergoes a series of cascading reduction steps, resulting in termination products Generally Recognized As Safe. | 2012-08-16 |
20120207859 | CALCIUM CARBONATE GRANULATION - Highly compactable granulations and methods for preparing highly compactable granulations are disclosed. More particularly, highly compactable calcium carbonate granulations are disclosed. The granulations comprise powdered materials such as calcium carbonate that have small median particle sizes. The disclosed granulations are useful in pharmaceutical and nutraceutical tableting and provide smaller tablet sizes upon compression than previously available. | 2012-08-16 |
20120207860 | ANTI-FUNGAL COMPOSITION - The present invention relates to an improved anti-fungal composition, to a process for preparing it and to its use as a preservative. | 2012-08-16 |
20120207861 | BIOCIDAL COMPOSITION AND METHOD FOR TREATING RECIRCULATING WATER SYSTEMS - The present invention is directed to a composition for treating recirculating water systems, comprising: (1) a biocidal effective amount of a first nonoxidizing biocide comprising biguanide; and (2) a biocidal effective amount of a second nonoxidizing biocide comprising dibromonitrilopropionamide (DBNPA); wherein the composition is substantially free from oxidants. The present invention is also directed to a method of controlling the growth of microorganisms in recirculating water systems, comprising the step of treating the recirculating water systems with the above composition. | 2012-08-16 |
20120207862 | ORAL INHIBITORS OF AGE-RELATED NADH OXIDASE (arNOX), COMPOSITIONS AND NATURAL SOURCES - Described are compositions and agents for blocking serum and other aging factors, especially arNOX in serum, skin or other body fluid or tissue and/or on the cell surface, and methods for using the same. More particularly, the invention relates to agents comprising any one of several naturally-occurring arNOX inhibitors capable of reducing occurrence or severity of or treating disorders and complications of disorders resulting from cell damage caused by aging-related isoforms of NADH oxidase (arNOX). In one exemplary embodiment, nutraceutical, cosmeceutical or pharmaceutical compositions comprise at least one naturally occurring arNOX inhibitor or inhibitor source. Such naturally occurring inhibitors also are capable of augmenting the anti-arNOX effect of other naturally occurring arNOX inhibitory agents. The discovery of multiple inhibitors with significantly different kinetics of inhibition that when combined provide long term arNOX inhibition is one of the unique and non-obvious features of the present methods and compositions. | 2012-08-16 |
20120207863 | Composition to enhance the bioavailability of curcumin - A composition for enhanced bioavailability of curcumin including purified curcuminoid and purified essential oil of turmeric. A method to prepare a composition for enhanced bioavailability of curcumin having purified curcuminoid and purified essential oil of turmeric. | 2012-08-16 |
20120207864 | THERMALLY INSULATED DIE PLATE ASSEMBLY FOR UNDERWATER PELLETIZING AND THE LIKE - An insulated die plate assembly for use in underwater pelletizing and other granulation processes includes a thin, continuous air chamber formed across the plate assembly generally parallel to the die face such that the heated upstream portion of the die plate assembly is thermally insulated from the downstream portion. The air chamber is atmospherically equilibrated by venting the air chamber to the atmosphere. The plurality of extrusion orifices, either individually or in groups, are formed in extrusion orifice extensions that extend through the insulation chamber so that the process melt to be granulated can pass therethrough. The orifice extensions and the components forming the air chamber around the orifice extensions channel heat along said extensions to maintain the process melt therein at a desired temperature, to help rigidify the die plate assembly and to better seal the air chamber. | 2012-08-16 |
20120207865 | MOLD-FORMING SUBSTRATE AND INSPECTION METHOD - A circular mold-forming substrate of 125-300 mm diameter having a surface on which a topological pattern is to be formed is provided wherein the thickness of the substrate has a variation of up to 2 μm within a circle having a diameter of 125 mm. | 2012-08-16 |
20120207866 | Double-Flow Screw Spindle Machine - The invention relates to a double-flow screw spindle machine for drive generation by multiphase mixtures or for the delivery of multiphase mixtures, comprising at least two separate inlet chambers ( | 2012-08-16 |
20120207867 | FACILITY FOR PRODUCING A SOLID PRODUCT USING ONE OR MORE POWDER MATERIALS - A facility for using powder materials to produce a solid product having multiple layers includes a supply of powder material(s), a die for receiving the powder material(s) and shaping the solid product, the die being secured in a reversible manner to a die-holding table secured to the frame of the facility, and translatable upper and lower punches that engage with one another at the die to compress the powder material(s). The lower punch is connected to a system for uncoupling the members that provide the movement thereof, the system having a brake for limiting the downward travel of the lower punch to keep it in contact with the powder material contained in the die when producing the solid product to avoid the generation of additional compression during the receipt of powder material in the die during the intermediate filling phases for each layer of the product. | 2012-08-16 |
20120207868 | ENHANCED SEPARATION OF INJECTION MOLDED MICROLENSES FOR HIGH VOLUME MANUFACTURING - A method and system for enhanced demolding of injection molded optical devices are disclosed. In one embodiment the system includes a metal moldplate without a coat of release layer and a curing device that generates high intensity pulses of UV light. The method includes: providing a moldplate made of a predetermined moldplate material; directly injecting optical material into cavities of a moldplate without a release layer; rapidly curing the injected optical material with high intensity pulses of UV light such that a predetermined optical device is formed; and separating the thus formed optical device from the cavities of the moldplate due to a differential thermal expansion between the optical device material and the moldplate material. | 2012-08-16 |
20120207869 | Cutting Tool, Method for Manufacturing Molding Die, and Molding Die for Array Lens - A cutting tool including a cutting blade, a shank section, and a supporting member for supporting and fixing the cutting blade, the cutting blade being fixed on one end of the supporting member, and the other end of the supporting member being fixed to the shank section, wherein a void formed among the shank section, the cutting blade, and the supporting member is filled with a filling agent. | 2012-08-16 |
20120207870 | DEVICE FOR GRANULATING PLASTIC - A device is described for granulating plastic having a granulating head ( | 2012-08-16 |
20120207871 | FOLDING APPARATUS - A sailor roll includes pressing rolls and a center roll provided between the pressing rolls the center roll configured to press a central region of a web. The portions of the web pressed down by the pressing rolls serve as a fold origin from which the web is folded. Each of the pressing rolls has a tapered shape in which the diameter becomes smaller toward the outer side in the cross direction CD. In other word, the pressing rolls respectively have tapered surfaces tapered toward a side region of the web. | 2012-08-16 |
20120207872 | BLOW NOZZLE TO CONTROL LIQUID FLOW WITH PRE-STRETCH ROD ASSEMBLY AND METAL SEAT SEAL PIN - An apparatus for forming a container from a container preform. The apparatus includes a housing, a mold cavity, and a nozzle system disposed in the housing and operably connectable to the mold cavity. The nozzle system is positionable between a first position engaging the housing along an interface of contact preventing pressurized liquid from being injected into the container preform and a second position spaced apart from the housing permitting pressurized liquid to be injected into the container preform. The nozzle system further includes in some embodiments a seal portion having a first surface—the first surface engaging a second surface extending from the housing in the first position. | 2012-08-16 |
20120207873 | REVERSE STRETCH ROD FOR MACHINE HYGIENE AND PROCESSING - A mold device for forming a plastic container from a preform. The mold device comprises a mold defining a mold cavity and a central exterior rod system moveably disposed within the mold cavity. The central exterior rod system is positionable between an extended position engagable with the preform and a retracted position spaced apart from the preform. The central exterior rod system maintains a central orientation of the preform during formation. | 2012-08-16 |
20120207874 | Container Having A Rim Or Other Feature Encapsulated By Or Formed From Injection-Molded Material - A tool for creating a container or tray having various features. The tool comprises a cavity operable to receive a blank. The cavity has at least one sidewall for forming at least one sidewall of the container. A core is operatively connected to the cavity. The core is operable to enter the cavity to least partially form the blank into the container. An injection cavity is for receiving liquid resin and directing liquid resin around at least a portion of the perimeter of the blank. The injection cavity comprises an advanced-flow section and a delayed-flow section. The advanced-flow section has a greater cross-sectional area than the delayed-flow section, and the advanced-flow section is located adjacent the at least one sidewall of the cavity. | 2012-08-16 |
20120207875 | CO-EXTRUDED LAYERED CANDY AND GUM APPARATUS AND METHODS - Methods and apparatus are provided for preparing multi-layered confectionery compositions. The multi-layered confectionery compositions are formed using a co-extrusion process of at least two different confectionery compositions that have at least one visual or sensorial distinction. The tolerances of the resulting pieces of the multi-layered confectionery composition are maintained such that the pieces can be packaged in rigid packaging. The processing parameters of processing of the plurality of confectionery compositions prior to the step of cutting and wrapping the pieces can be altered so as to maintain the average piece size within a predetermined tolerance level. | 2012-08-16 |
20120207876 | Food Product With Biocontrol And Method - A packaged food product and method are provided. The product includes biocontrol microorganisms adhered at least initially to a closure member that is attached to a container in which food product is contained. At least some of the biocontrol microorganisms are transferred to the food product after the closure member is attached to the container. | 2012-08-16 |
20120207877 | OLIGO-SACCHARIDE ENHANCED OAT-BASED DRINK FOR TREATING HYPERLIPIDAEMIA AND HYPERGLYCEMIA AND IMPROVING GASTROINTESTINAL FUNCTION AND PROCESS FOR PREPARING THE SAME BY TRI-ENZYME HYDROLYSIS AND MICRO-PARTICLE MILLING - The invention relates to a tri-enzyme hydrolysis method for preparing an oligo-saccharide enhanced oat-based drink product useful in lowering cholesterol, triglyceride, blood sugar and improving gastrointestinal function which comprises not only oat β-glucan and but also a higher amount of isomalto-oligosacchride. In accordance with the invention, whole grains of oats are micronized to an average particle size of 100 microns prior to enzyme treatments, and a product of creamy milk-like texture is obtained without filtration so that nutrients of the whole grains of oats are retained. This invention enhances the value of oat-based processing to yield additional health-associated content and illness (such as hyperlipidaemia and hyperglycemia) prevention efficacy that are beyond the potential of oats per se. | 2012-08-16 |
20120207878 | LOW-FAT OR FAT-FREE YOGHURT, AND PROCESS FOR PRODUCTION THEREOF - A fat-free or low-fat yoghurt having a rich and creamy texture like yoghurts produced using whole-fat milk may be produced by adding a proper amount of a milk protein, such as a defatted milk powder, that has been deamidated with a protein deamidating enzyme to a fat-free or low-fat raw material milk. Alternatively, a proper amount of a milk protein, such as a defatted milk powder, is added to a fat-free or low-fat raw material milk, and the resulting mixture is subjected to a deamidation treatment with a protein deamidating enzyme so that the deamidation ratio reaches a proper level. In this manner, a fat-free or low-fat milk raw material having a milk protein mass and a deamidation ratio both falling within proper ranges can be prepared, and yoghurt may be produced using the milk raw material. | 2012-08-16 |
20120207879 | Quick Dry Process for Drying Meat - Semi-dry or dry sausage, and method of preparing semi-dry or dry sausage, including removing moisture from cooked and diced or sliced meat using hot oil. The semi-dry or dry sausage may be prepared by mixing raw ground meat and seasoning, extruding the seasoned ground meat, cooking the extruded meat, dicing or slicing the extruded meat, and immersing the cooked diced or sliced meat in oil at a time and temperature sufficient to remove moisture from the cooked meat to form a semi-dry or dry sausage. The time and temperature can be selected to achieve a desired moisture to protein ratio in the sausage. | 2012-08-16 |
20120207880 | GLUTEN ADDITIVES FOR RICE BAKERY AND PREPARATION METHOD THEREOF - The present disclosure provides: (a) a composition for preparing gluten-free wet rice noodle, rice cake, baked rice confectionery, rice cookie and rice bread, (b) gluten-free wet rice noodle, rice cake, baked rice confectionery, rice cookie and rice bread, and (c) a method for preparing the same. The present disclosure not only provides superior gustatory sensation over wet wheat noodle, wheat cake, baked wheat confectionery, wheat cookie and wheat bread but also provides well-being diet cake for health improvement in terms of nutrition since intake of sugar and sweet substances as well as fats can be reduced. In addition, the present disclosure will find useful applications in the well-being health food industry and the agricultural processed food industry since wheat allergy can be avoided owing to the absence of wheat and the gluten-free food is of great help to patients with celiac disease or atopy. | 2012-08-16 |
20120207881 | ACTIVE INGREDIENT DELIVERY SYSTEM - Object of the invention is to provide an ingredient delivery system that is particularly suitable for use in flour based dough. This object is met by providing a method for preparing a dough product, comprising subjecting a dough to a heat treatment, wherein the dough has been prepared by mixing (i) water, (ii) non-pelletized flour and (iii) one or more pellets comprising pelletized flour and an active ingredient. | 2012-08-16 |
20120207882 | THERAPEUTIC USE OF MUCIN GLYCANS - A therapeutic formulation containing mucin glycans derived from one or a number of nutritionally appropriate sources is described. | 2012-08-16 |
20120207883 | ALKALINE BOOSTER WITH ANTIOXIDANTS - A highly alkaline, ultra-low sodium solution of saturated tripotassium phosphate may be used as an additive to dosages such as concentrated drops, tablets, capsules, bottled water, beverages or other dosage forms. The additive further includes organic potassium, calcium, zinc, magnesium, selenium and 79 trace minerals from ancient sea salt. The trace minerals are taken from the low-sodium technical magnesium chloride marine deposits and chelated with amino acids. The amino acids are from a non-animal source which is suitable for vegetarian and persons who are allergic to animal proteins. The additive, which is considered nutritionally nil in sodium content, can be used as a concentrated aqueous drop or dried and used as an additive for dietary supplement dosage forms including tablets, capsules, bottled water, beverages and others. | 2012-08-16 |
20120207884 | EDIBLE GLUES AND APPLICATORS FOR SAME - Described herein are edible glues and customized applicators for delivering the same. | 2012-08-16 |
20120207885 | Multidirectional Fuse Susceptor - A microwave energy interactive structure includes microwave energy interactive material supported on a microwave energy transparent substrate, and a plurality of spaced apart microwave energy transparent segments circumscribed by the microwave energy interactive material. The plurality of spaced apart microwave energy transparent segments define a pattern of loops that may be dimensioned to induce resonance of microwave energy during microwave heating of a food item on the structure. The structure may also include a plurality of microwave energy transparent elements that are operative as fuses to prevent overheating of the structure. | 2012-08-16 |
20120207886 | System and method of preparing frozen baking items - A method of preparing a frozen mixture that may be thawed and baked without adding additional ingredients is provided. A mixture is prepared, placed into an oversized pastry bag, and frozen. Air is evacuated from the bag which is then heat sealed. The frozen mixture can be distributed for purchase by customers at retail outlets. The product can be thawed, kneaded, and piped from the bag directly into a baking mold. If desired, flavoring or other ingredients may be added during or following the thawing stage, and can be kneaded prior to piping. | 2012-08-16 |
20120207887 | PRINTED FLEXIBLE FILM FOR FOOD PACKAGING - The printed image on a major face of a flexible food packaging film is covered by a shellac barrier coating. | 2012-08-16 |
20120207888 | Comestible Coating Delivery Method and Apparatus - The present invention relates to an improved apparatus and method for delivering a coating substance and to an improved apparatus for delivering a powder coating to glutinous products such as confectionary/bakery, gum and dough-like products in a manufacturing and/or packaging procedure. Chewing gum is typically produced by combining chewing gum components, extruding and subsequently rolling a gum composition into a uniform flat sheet of a desired thickness and width. During processing, the extruded material must pass through a series of rollers to produce the ultimate product. In a conventional process, a rolling compound or powdered non-stick agent may be applied to the sheet during processing to avoid fouling of the rollers by a tacky material. Present systems for the application of dusting are inefficient and lead to the loss of much powder. The present invention seeks to provide an improved system. | 2012-08-16 |
20120207889 | SYSTEM AND METHOD FOR COST-EFFECTIVE PRODUCTION OF A DEHYDRATED FOOD PRODUCT - Raw beans are hydrated in a hydration/wetting liquid (water or a broth of water and bean solids) in a stationary hydration vessel for an amount of time sufficient to obtain uniformly hydrated beans. In one embodiment, more wetting liquid than necessary is used. In this embodiment, the hydrated beans are separated from the excess wetting liquid remaining at the end of hydration, and all of the excess wetting liquid is used to hydrate subsequent raw beans. In a second embodiment, the hydration liquid is of an amount such that, at the end of hydration, the hydration vessel is substantially free of excess wetting liquid; here, the beans may be agitated during hydration so as to be maintained in uniform contact with the hydration liquid. In all embodiments, the hydrated beans are then steam cooked in a separate stationary cooking vessel that contains no wetting liquid. | 2012-08-16 |
20120207890 | Salt Composition - A low sodium salt composition and method for manufacture are provided. The composition generally includes salt, such as sodium chloride, and one or more crystallization interrupters. The composition is in the form of amorphous particles, optionally in combination with other ingredients. | 2012-08-16 |
20120207891 | Egg Poacher and Method for Poaching - An egg poacher includes a cup having a bottom, a side wall extending upward from a perimeter of the bottom, an open top at a top edge of the side wall, and a plurality of perforations formed through the side wall but not through the bottom. The egg poacher may have a handle connected to a part of the side wall. The handle may be curved. A method of poaching an egg includes the steps of selecting an egg poacher, placing the egg poacher in a pan of simmering water, cracking open and placing a raw egg contents in the cup, cooking the egg contents, lifting and draining water from the cup, and releasing the cooked egg. | 2012-08-16 |
20120207892 | FABRICATED FOOD PRODUCT MADE FROM FRESH POTATO MASH - A composition and method for providing a strong dough having a substantial quantity of fresh potatoes. Fresh potatoes are made into a mash and centrifuged to reduce the water content to about 70% by weight. Such potato mash can comprise over 50% by weight of the final dough. This dough can be used to make sheeted or extruded products. Such dough results in improved, more naturally-flavored products compared to products made entirely from dehydrated or partially-dehydrated potato derivatives. The method comprises finely slicing potatoes to form a potato slurry or mash; decanting excess water from the potato slurry; heating the potato slurry to a temperature no greater than about 190 degrees Fahrenheit; cooling the slurry to under 140 degrees Fahrenheit; and imparting a low amount of work input to a mixture of the slurry and other ingredients to form a shapeable dough. | 2012-08-16 |
20120207893 | Brewing Device and Method for Extracting a Portion Capsule - The invention proposes a brewing apparatus for extracting a portion capsule, having an accommodation element, which has a cavity for the portion capsule, and a closure element, it being possible for the closure element to move between a loading position, which is at a distance from the accommodation element, and an extraction position, which closes the cavity, and the brewing apparatus having a holding element for holding the portion capsule in the loading position, and furthermore the holding element being designed in such a way that the portion capsule is aligned substantially in the direction of the accommodation element by the holding element by virtue of the movement of the closure element from the loading position to the extraction position. | 2012-08-16 |
20120207894 | Beverage flavoring pod ejection system and method - A mechanical waste pod ejector system for a single cup pod beverage flavoring machine that has a lower head with a holding chamber therein, for holding a pod during a flavoring operation, which head mechanically ejects the pod after usage. The system includes a pod ejector mechanism, a pod support plate sized to engage the pod, and actuator head, with a pod ejector controller including a cam slide surface for moving the lower head from a flavoring position to a pod disposal position. | 2012-08-16 |
20120207895 | Single Serving Reusable Brewing Material Holder - A single serving beverage filter cartridge is formed by placing a single serving portion of brewing material into a reusable coffee holder having a lid and a base. The reusable coffee holder includes a recessed annular region at the bottom of a base of the holder and is insertable into a cartridge housing of a single serving coffee maker having an offset needle reaching up vertically from the base of the housing, the recessed annular region avoiding the offset bottom needle. The coffee holder defines a frustoconical exterior and includes mesh filtering material for retaining brewing material inside the coffee holder. The mesh material may be a metal mesh or plastic mesh. The reusable coffee holder is configured for use in single serving coffee makers having the offset bottom needle and designed for single use cartridges. | 2012-08-16 |
20120207896 | Single Serving Reusable Brewing Material Holder With Offset Passage for Offset Bottom Needle - A single serving beverage filter cartridge is formed by placing a single serving portion of brewing material into a reusable coffee holder having a lid and a base. The reusable coffee holder includes an offset passage in the bottom of the base and is insertable into a cartridge housing of a single serving coffee maker having an offset bottom needle reaching up vertically from the base of the housing, the offset passage providing clearance for the offset bottom needle. The coffee holder defines a frustoconical exterior and includes mesh filtering material for retaining brewing material inside the reusable coffee holder. The mesh material may be a metal mesh or plastic mesh. The reusable coffee holder is configured for use in single serving coffee makers having the offset bottom needle and designed for single use cartridges. | 2012-08-16 |
20120207897 | INSTANT NOODLES AND METHOD FOR PRODUCING THE SAME - The present invention provides a method for producing instant noodles which have an excellent reconstitution property and excellent taste and texture and can be reconstituted by pouring boiling water even if the noodles are thicker than before. In the method for producing the instant noodles, a noodle belt is extremely strongly rolled out once or more at a rolling rate of 60% or higher in a noodle belt rolling step, raw noodle strings are obtained from the noodle belt, superheated steam is sprayed to the obtained raw noodle strings, moisture is supplied or not supplied to the noodle strings, the noodle strings are steamed by saturated steam or superheated steam or are boiled to realize gelatinization, and the noodle strings are dried after the gelatinization. | 2012-08-16 |
20120207898 | HIGH EFFICIENCY APPARATUS AND METHOD FOR LIQUID SMOKE GENERATION - This invention relates to a high efficiency apparatus for manufacturing an aqueous wood smoke solution in the form of a liquid smoke desired concentration, and a method of obtaining such aqueous solution using the same apparatus by burning wood, wooden chips or sawdust in a limited amount of air. The apparatus and process disclosed herein is simple, safe, and clean. Wood consumption per unit of liquid smoke is significantly smaller comparing to conventional methods, while the air pollution is reduced to a negligible level. | 2012-08-16 |
20120207899 | METHOD AND APPARATUS FOR CUTTING DOUGH PRODUCTS HAVING HOLES FROM A DOUGH SHEET - A stamping apparatus may be used to cut a dough product having a hole from a dough sheet. The stamping apparatus may have multiple cutting blades, depending from a platen, that are configured for cutting complementary open shapes, in phases, that together form a closed shape defining the dough product periphery. The stamping apparatus may also have a tubular cutting blade depending from the platen, configured to cut a closed shape defining the dough product hole, that is nested within one of the blades that is configured to cut an open shape. The tubular cutting blade may be retractable about a finger contained therewithin that remains in a fixed position in relation to the tubular cutting blade as the blade retracts. Air trapped within the tubular cutting blade, between the finger and a cutout dough piece that does not form part of the dough product, may become compressed during blade retraction. The compression may facilitate ejection of the cutout dough piece from the tubular cutting blade. The finger may be omitted in some embodiments. | 2012-08-16 |
20120207900 | Method of making pasta filata cheese without cooling in brine or other liquid - A method of making pasta filata cheese (and the resulting cheese) uses a conventional pasta filata cheese making process except that the cheese mass, after cooking and stretching, is not cooled in brine or other liquid. Instead, the cheese is cooled through other means, such as by being rolled into the form of a sheet on a conveyor, and then cooled on the conveyor. The cheese may be (but need not be) frozen on the conveyor or thereafter, and comminuted. | 2012-08-16 |
20120207901 | INFLATABLE CUSHION - An inflatable cushion useable for an ice cream maker. The ice cream maker can be spherical in shape and the inflatable cushion can approximate a spherical or dodecahedron shell. The inflatable cushion can be comprised of two half-shell portions that are pivotable with respect to one other to be selectively placed in a closed or open position. The ice cream maker can be snugly inserted within the inflatable cushion. | 2012-08-16 |
20120207902 | METHOD OF EXTENDING THE PRODUCTION TIME OF A PASTEURISER - The invention relates to a method of extending the production time of a pasteuriser. The pasteuriser is of the type which includes a plate heat exchanger with a number of sections, of which at least one section consists of regenerative section. The method comprises raising the temperature in the downstream part of the regenerative section to a temperature above 50° C., during a certain predetermined period of time and at regular intervals. During normal production, a part quantity of the product which passes downstream of the regenerative section is shunted past the regenerative section. At the regular intervals and during the predetermined period of time, a part quantity of the product which passes upstream of the regenerative section is shunted past the regenerative section. At the same time, all product passes the downstream part of the regenerative section during the predetermined period of time. | 2012-08-16 |
20120207903 | Consumer Wine Additive - The present invention provides a method for a consumer to enhance the quality of an average glass or carafe of wine by placing an additive into the glass or carafe and allowing its ingredients to mix with the wine. The mixture of food grade chemicals and natural sweeteners improves the wine drinking experience in the major physical and sensory aspects that make for an above average wine. These include: a smoky oak flavor, improved sweetness of the fruit, a toasty or roasted coffee aroma and aftertaste, the hint of spices and scents such as leather, tobacco, nutmeg, basil, rosemary, earthiness. Beyond enhancing the taste of the wine, certain hygroscopic constituents of the present invention improve mouth feel of the treated wine and increase the length of the finish of the wine, the length of time the flavors linger on the palate. The method of the present invention allows a wine consumer to improve their sensory experience while drinking the treated wine. All of this is done without changing the basic underlying balance of acidity and fruit of the original wine. The pH is not disturbed with this additive which can be stored in individual plastic or foil pouches or containers intended to be carried in the pocket when dining out. | 2012-08-16 |
20120207904 | Gluten Free Structured Protein Product - The invention relates to a structured protein product comprised of a texturizable protein and a binding agent. The invention also relates to a method for extruding a wheat-free, and more particularly, gluten-free structured protein product with substantially aligned protein fibers. The method also works for wheat-containing blends. | 2012-08-16 |